Abstract
Renal patients are particularly vulnerable to infection. They are relatively immunocompromised and undergo numerous invasive procedures, which put them at risk of infection. They receive multiple antibiotics, which select out resistant organisms and attend healthcare environments on a frequent basis, allowing ample opportunity for multidrug-resistant organisms to spread. Many patients are on immunosuppressive agents to treat their underlying renal disease or following a kidney transplant.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Sarnak MJ, Jaber BL. Mortality caused by sepsis in patients with end-stage renal disease compared with the general population. Kidney Int. 2000;58(4):1758–64.
WHO guidelines on hand hygiene in health care. 2009. http://whqlibdoc.who.int/publications/2009/9789241597906_eng.pdf.
Shahid NS, et al. Hand washing with soap reduces diarrhoea and spread of bacterial pathogens in a Bangladesh village. J Diarrhoeal Dis Res. 1996;14(2):85–9.
Luby SP, et al. Effect of intensive handwashing promotion on childhood diarrhea in high-risk communities in Pakistan: a randomized controlled trial. JAMA. 2004;291(21):2547–54.
Cardoso CL, et al. Effectiveness of hand-cleansing agents for removing Acinetobacter baumannii strain from contaminated hands. Am J Infect Control. 1999;27(4):327–31.
Gordin FM, et al. Reduction in nosocomial transmission of drug-resistant bacteria after introduction of an alcohol-based handrub. Infect Control Hosp Epidemiol. 2005;26(7):650–3.
Pratt RJ, et al. The epic project: developing national evidence-based guidelines for preventing healthcare associated infections. Phase I: guidelines for preventing hospital-acquired infections. Department of Health (England). J Hosp Infect. 2001;47(Suppl):S3–82.
Public Health Laboratory Service AIDS and STD Centre. Occupational transmission of HIV. London; 1999.
Haley RW, et al. Update from the SENIC project. Hospital infection control: recent progress and opportunities under prospective payment. Am J Infect Control. 1985;13(3):97–108.
Piraino B, et al. Peritoneal dialysis-related infections recommendations: 2005 update. Perit Dial Int. 2005;25(2):107–31.
Engemann JJ, et al. Clinical outcomes and costs due to Staphylococcus aureus bacteremia among patients receiving long-term hemodialysis. Infect Control Hosp Epidemiol. 2005;26(6): 534–9.
Simor AE. Staphylococcal decolonisation: an effective strategy for prevention of infection? Lancet Infect Dis. 2011;11(12):952–62.
Tacconelli E, et al. Mupirocin prophylaxis to prevent Staphylococcus aureus infection in patients undergoing dialysis: a meta-analysis. Clin Infect Dis. 2003;37(12):1629–38.
Fluck R, Kumwenda M. Renal association guidelines – vascular access for haemodialysis; 2011. www.renal.org/guidelines/modules/vascular-access-for-haemodialysis.
Woodrow G, Davies S. Clinical practice guidelines: peritoneal dialysis. UK Renal Association; 2010. www.renal.org/guidelines/modules/peritoneal-dialysis-in-ckd.
Clostridium difficile infection: how to deal with the problem. 2008. www.hpa.org.uk/webc/hpawebfile/hpaweb_c/1232006607827.
Cornely OA, et al. Fidaxomicin versus vancomycin for infection with Clostridium difficile in Europe, Canada, and the USA: a double-blind, non-inferiority, randomised controlled trial. Lancet Infect Dis. 2012;12(4):281–9.
Louie TJ, et al. Fidaxomicin versus vancomycin for Clostridium difficile infection. N Engl J Med. 2011;364(5):422–31.
Klevens RM, et al. Dialysis Surveillance Report: National Healthcare Safety Network (NHSN)-data summary for 2006. Semin Dial. 2008;21(1):24–8.
Hannah EL, et al. Outbreak of hemodialysis vascular access site infections related to malfunctioning permanent tunneled catheters: making the case for active infection surveillance. Infect Control Hosp Epidemiol. 2002;23(9):538–41.
O’Grady N, Alexander M, Burns L, Dellinger E, Garland J, O’Heard S, Lipsett P, Masur H, Mermel L, Pearson M, Raad I, Randolph A, Rupp M, Saint S. The Healthcare Infection Control Practices Advisory Committee (HICPAC). Guidelines for the preventions of intravascular catheter-related infections. Clin Infect Dis. 2011;52(9):e162–93.
Chatzinikolaou I, et al. Antibiotic-coated hemodialysis catheters for the prevention of vascular catheter-related infections: a prospective, randomized study. Am J Med. 2003;115(5):352–7.
Chaiyakunapruk N, et al. Chlorhexidine compared with povidone-iodine solution for vascular catheter-site care: a meta-analysis. Ann Intern Med. 2002;136(11):792–801.
NKF KDOQI Guidelines: clinical practice guidelines for vascular access. 2006. www.kidney.org/PROFESSIONALS/kdoqi/guideline...PD.../index.htm.
Lok CE, Mokrzycki MH. Prevention and management of catheter-related infection in hemodialysis patients. Kidney Int. 2011;79(6):587–98.
Lok CE, et al. Hemodialysis infection prevention with polysporin ointment. J Am Soc Nephrol. 2003;14(1):169–79.
Yahav D, et al. Antimicrobial lock solutions for the prevention of infections associated with intravascular catheters in patients undergoing hemodialysis: systematic review and meta-analysis of randomized, controlled trials. Clin Infect Dis. 2008;47(1):83–93.
Piraino B, et al. ISPD position statement on reducing the risks of peritoneal dialysis-related infections. Perit Dial Int. 2011;31(6): 614–30.
Figueiredo A, et al. Clinical practice guidelines for peritoneal access. Perit Dial Int. 2010;30(4):424–9.
Dombros N, et al. European best practice guidelines for peritoneal dialysis. 3 Peritoneal access. Nephrol Dial Transplant. 2005;20 Suppl 9:ix8–12.
Strippoli GF, et al. Catheter-related interventions to prevent peritonitis in peritoneal dialysis: a systematic review of randomized, controlled trials. J Am Soc Nephrol. 2004;15(10):2735–46.
Nessim SJ, Bargman JM, Jassal SV. Relationship between double-cuff versus single-cuff peritoneal dialysis catheters and risk of peritonitis. Nephrol Dial Transplant. 2010;25(7):2310–4.
Bernardini J, et al. Randomized, double-blind trial of antibiotic exit site cream for prevention of exit site infection in peritoneal dialysis patients. J Am Soc Nephrol. 2005;16(2):539–45.
Churchill DN, et al. Canadian hemodialysis morbidity study. Am J Kidney Dis. 1992;19(3):214–34.
Englesbe MJ, et al. Single center review of femoral arteriovenous grafts for hemodialysis. World J Surg. 2006;30(2):171–5.
Zibari GB, et al. Preoperative vancomycin prophylaxis decreases incidence of postoperative hemodialysis vascular access infections. Am J Kidney Dis. 1997;30(3):343–8.
van Loon MM, et al. Buttonhole needling of haemodialysis arteriovenous fistulae results in less complications and interventions compared to the rope-ladder technique. Nephrol Dial Transplant. 2010;25(1):225–30.
Nesrallah GE, et al. Staphylococcus aureus bacteremia and buttonhole cannulation: long-term safety and efficacy of mupirocin prophylaxis. Clin J Am Soc Nephrol. 2010;5(6):1047–53.
Report of the Rosenheim Advisory Group. Hepatitis and the treatment of chronic renal failure. London: Department of Health and Social Security; 1972.
Department of Health (UK). Good practice guidelines for renal dialysis/transplantation units: prevention and control of blood-borne virus infection. London: Department of Health (UK); 2002.
Kidney Disease: Improving Global Outcomes (KDIGO). KDIGO clinical practice guidelines for the prevention, diagnosis, evaluation, and treatment of hepatitis C in chronic kidney disease. Kidney Int Suppl. 2008;73(109):S1–99.
Canadian Society of Nephrology guidelines for prevention of blood borne infections in dialysis units. CANNT J. 2007. www.thefreelibrary.com.
Jadoul M, Cornu C, van Ypersele de Strihou C. Universal precautions prevent hepatitis C virus transmission: a 54 month follow-up of the Belgian Multicenter Study. The Universitaires Cliniques St-Luc (UCL) Collaborative Group. Kidney Int. 1998;53(4): 1022–5.
Department of Health (UK). Good practice guidelines for renal dialysis/transplantation units, prevention & control of blood-borne virus infection. Addendum guidelines for dialysis away from base. London: Department of Health (UK); 2010.
Department of Health. Immunisation against infectious disease – ‘The Green Book’ – 2006 updated edition. 2nd ed. London: Department of Health (UK); 2007.
NICE guideline: clinical diagnosis and management of tuberculosis, and measures for its prevention and control. 2011. www.nice.org.uk/nicemedia/live/13422/53642/53642.pdf.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer-Verlag London
About this chapter
Cite this chapter
Collier, S., Hopkins, S. (2014). Prevention of Infection in Kidney Patients. In: Harber, M. (eds) Practical Nephrology. Springer, London. https://doi.org/10.1007/978-1-4471-5547-8_57
Download citation
DOI: https://doi.org/10.1007/978-1-4471-5547-8_57
Published:
Publisher Name: Springer, London
Print ISBN: 978-1-4471-5546-1
Online ISBN: 978-1-4471-5547-8
eBook Packages: MedicineMedicine (R0)